It's a foregone conclusion that gummies are the cornerstone of the legal edibles market, especially on the West Coast. When convenience, discretion, and precise dosing are the name of the…
TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that Endocanna Health (“Endocanna”), a ... Read More
It’s been a whirlwind rise for psychedelics in general in the past few years, with tons of research into medical properties, and new legal policies being set in different parts of the country to allow medical use, or decriminalize recreational use. What’s in store for this class of drugs? Here are my 2022 predictions for […]
Pennsylvania is set to become a national, and possibly global, leader in psilocybin research, thanks to a new bill that was recently introduced in the House of Representatives. The bill passed a Health Committee vote in Harrisburg and is on its way for votes in the house and senate. Titled the Public Health Benefits of […]
We have reached a turning point in the cannabis industry, where, as consumers, we now have more choices than we know what to do with. When I was younger, shopping for weed consisted of calling one of the 3 or 4 dealers in my area and picking up whatever flower strain was available from whoever […]
In this week’s update on patents – India requests emergency meeting of WTO General Council to discuss patent waiver; RGNIIPM announces online advanced training program on patent specification; Taiwan’s revised ‘Accelerated Examination Program’ (AEP) comes into effect from January 01, 2022; USPTO pushes deadline for applications under COVID-19 Prioritized Pilot Program to March 31st, 2022; Novartis announces CAFC ruling on validity of Gilenya patent; Intel can challenge two of Qualcomm’s smartphone patents, says U.S. Court of Appeals. India related patent…
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan ... Read More
To carry out the study, retrospective clinical data was collected by researchers from clinicians and caretakers of 10 children with drug-resistant epilepsy. The researchers ensured that the 10 patients recruited for the research had not responded to any CBD products. The children recruited were of the average age of six but ranged between 1 to 13 years. These kids had a range of epilepsies and various kinds of co-existing issues like learning abilities, global developmental delay, and infantile spasms.
Perhaps the most iconic yet misunderstood, hallucinogenic mushroom species on earth is none other than the Amanita muscaria, also known as the fly agaric mushroom. This toadstool mushroom species is one of the oldest types of psychoactive fungi to be used by humans, that we know of, and it is represented somewhat widely in the […]
Sometimes we argue over cannabis laws and what should be legal. Sometimes we argue over cannabis uses and what the plant can do. Sometimes we argue over the commercial industry and all the problems therein, and sometimes we argue over products and which ones are best. Today isn’t about arguing though, it’s simply about enjoying […]